NCT00114764View on ClinicalTrials.gov

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

August 31, 2004

Conditions
Myeloid Leukemia
Interventions
DRUG

filgrastim

Filgrastim given daily after induction chemotherapy

DRUG

pegfilgrastim

Pegfilgrastim given once after induction chemotherapy

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00114764 - Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) | Biotech Hunter | Biotech Hunter